Mayo Clinic selects AI-based diagnostics company to join accelerator program

Mediwhale, a South Korean artificial intelligence-powered health diagnostics company, has been selected for the MedTech Accelerator, an entrepreneurial and business development program for healthcare companies put on by Rochester, Minn.-based Mayo Clinic and Tempe-based Arizona State University. 

The 12-month program will support Mediwhale in developing go-to-market plans and investment opportunities as the company looks to achieve FDA approval and expand into the U.S. market. 

The company uses deep-learning algorithms to predict disease risk through retinal scans. 

Currently, Mediwhale's scans focus on cardiovascular, aging, kidney and eye health. The eye program shows a minimum 96 percent accuracy, according to a March 21 Mediwhale news release shared with Becker's.

The MedTech Accelerator is the third active accelerator program Mediwhale has joined in the U.S.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars